Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

FDA Pre-Market Safety Assessment Program

Session Chair(s)

Vaishali  Popat, MD, MPH

Vaishali Popat, MD, MPH

Branch Chief, Office of Clinical Evaluation,Office of Therapeutic Products, CBER

FDA, United States

This session describes CDER initiatives to bring consistency and improve quality of pre-market safety assessments.

Learning Objective : Describe various new drug review modernization initiatives related to pre-market safety assessment happening at CDER; Discuss the reasons for the change and their impacts on pre-market safety assessment.

Speaker(s)

Scott  Proestel, MD

The FDA Medical Queries Project: This Will Significantly Change How We Do our Safety Signal Detection

Scott Proestel, MD

FDA, United States

Senior Medical Officer, ODES, OND, CDER, FDA

Preeti  Venkataraman, MD

The Standard Tables and Figures Visualization Project

Preeti Venkataraman, MD

FDA, United States

Physician, Biomedical Informatics & Regulatory Review Science, OND, CDER

Vaishali  Popat, MD, MPH

Data Integrity Project

Vaishali Popat, MD, MPH

FDA, United States

Branch Chief, Office of Clinical Evaluation,Office of Therapeutic Products, CBER

Mat  Soukup, PhD

Planning for Key Risks That are Undertaken Prior to Confirmatory Trial Initiation

Mat Soukup, PhD

FDA, United States

Deputy Director, Division of Biometrics VII, OB, OTS CDER

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.